AI-Enabled Stethoscope Boosts Diagnosis of Pregnancy-Related Cardiomyopathy
By Lori Solomon HealthDay Reporter
TUESDAY, Sept. 10, 2024 -- In pregnant and postpartum women, artificial intelligence (AI)-guided screening using a digital stethoscope improves the diagnosis of pregnancy-related cardiomyopathy, according to a study published online Sept. 2 in Nature Medicine to coincide with the European Society of Cardiology Congress 2024, held from Aug. 30 to Sept. 2 in London.
Demilade A. Adedinsewo, M.B.,Ch.B., from the Mayo Clinic in Jacksonville, Florida, and colleagues randomly assigned 1,195 pregnant and postpartum Nigerian women to usual care or AI-guided screening to assess its impact on the diagnosis of left ventricular systolic dysfunction (LVSD) in the perinatal period.
The researchers found that when using the AI-enabled digital stethoscope, the number of identified participants with LVSD detection was 24 out of 587 (4.1 percent) versus 12 out of 608 (2.0 percent) patients (intervention versus control odds ratio [OR], 2.12; 95 percent confidence interval [CI], 1.05 to 4.27). With the 12-lead AI-electrocardiogram model, the number of identified participants with LVSD detection was 20 out of 587 (3.4 percent) versus 12 out of 608 (2.0 percent) patients (OR, 1.75; 95 percent CI, 0.85 to 3.62).
"This study provides evidence that we can better detect peripartum cardiomyopathy among women in Nigeria. However, there are more questions to be answered," Adedinsewo said in a statement. "Our next steps would be to evaluate usability and adoption of this tool by Nigerian healthcare providers (including doctors and nurses) and importantly, its impact on patient care."
Several authors disclosed ties to relevant organizations.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
2023 Unintentional Fall Death Rate Was 69.9/100,000 in Those Aged 65 and Older
WEDNESDAY, June 18, 2025 -- For adults aged 65 years and older, the unintentional fall death rate was 69.9 per 100,000 population in 2023 and increased with increasing age...
FDA Offers Speedier Approvals to Drug Companies Aligning With 'National Priorities'
WEDNESDAY, June 18, 2025 -- On Tuesday, the U.S. Food and Drug Administration announced a new initiative to offer expedited reviews for new medicines, an initiative that will...
Waist-to-Height Ratio Predicts Liver Steatosis and Fibrosis
WEDNESDAY, June 18, 2025 -- Waist-to-height ratio (WHtR) outperforms body mass index (BMI) in detecting the risk for liver disease, according to a study published in the July...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.